Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)
$1.06 USD
Updated Jul 16 6:55pm
Add GNPX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
GNPX News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
The Expansion Continues for Aurora Cannabis (ACB)
Hexo Corp. (HEXO) began trading on the NYSE today, here’s what it means for the stock
Best & Worst Performing Stock Industries for July 16, 2019
Best & Worst Performing Small Cap Stocks for July 16, 2019
Best & Worst Performing Large Cap Stocks for July 16, 2019
View All Top StoriesGenprex, Inc. (GNPX) Company Bio
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.
GNPX Stock Chart More Charts
GNPX Price/Volume Stats
| Current price | $1.06 |
| Prev. close | $1.10 |
| Day low | $1.05 |
| Day high | $1.12 |
| 50-day MA | $1.45 |
| 200-day MA | $1.55 |
| 52-week high | $7.88 |
| 52-week low | $0.95 |
| Volume | 26,200 |
| Avg. volume | 38,556 |
| Dividend yield | N/A |
| Market Cap | 16.54M |
GNPX Returns
| 1-mo | -24.82% |
| 3-mo | -39.77% |
| 6-mo | -29.33% |
| 1-year | -85.83% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -3.64% |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...